Comprehensive overview of Antihyperlipidemic Drugs

Antihyperlipidemic Drugs

Classification, Pharmacokinetics, Mechanism of Action, Indications, Adverse Effects, Contraindications, and Drug Interactions

Introduction to Antihyperlipidemic Drugs

  • Used to lower lipid levels in the blood
  • Aim to prevent cardiovascular diseases
  • Act on different pathways involved in lipid metabolism
Classification of Antihyperlipidemic Drugs
  1. Statins (HMG-CoA reductase inhibitors)
    Eg. Simvastatin, Atorvastatin
  2. Fibrates (PPAR-α activators)
    Clofibrate, Gemfibrozil
  3. Bile Acid Sequestrants (Resins)
    Colestipol
  4. Inhibitor of Triglyceride Synthesis
    Nicotinic Acid (Niacin)
  5. Other Agents
    Omega Fatty Acids
Mechanism of Action of Statins
Inhibit HMG-CoA reductase enzyme
  • Reduce cholesterol synthesis in the liver
  • Increase LDL receptor expression → enhanced LDL clearance
  • Decrease plasma LDL and total cholesterol levels
Indications of Statins
  • Hypercholesterolemia
  • Prevention of cardiovascular diseases
  • Post-myocardial infarction patients
Adverse Effects of Statins
  • Muscle pain (myopathy, rhabdomyolysis in severe cases)
  • Hepatotoxicity (monitor liver enzymes)
  • Gastrointestinal disturbances
Contraindications of Statins
  • Pregnancy and lactation
  • Active liver disease
  • Drug interactions (e.g., CYP3A4 inhibitors increase statin levels)
Mechanism of Action of Fibrates
  • Activate PPAR-α receptors
  • Increase lipoprotein lipase activity → enhances triglyceride breakdown
  • Decrease VLDL and increase HDL levels
Contraindications of Fibrates
  • Hypertriglyceridemia
  • Type III hyperlipoproteinemia
Adverse Effects of Fibrates
  • Gallstone formation
  • Myopathy (increased risk when combined with statins)
  • Gastrointestinal disturbances
Contraindications of Fibrates
  • Severe hepatic or renal dysfunction
  • Gallbladder disease
  • Drug interactions (increased risk of myopathy with statins)
Mechanism of Action of Bile Acid Sequestrants
  • Bind bile acids in the intestine → prevent reabsorption
  • Increase conversion of cholesterol to bile acids → lowers LDL levels
Indications of Bile Acid Sequestrants
  • Hypercholesterolemia (adjunct therapy)
  • Used in patients who cannot tolerate statins
Adverse Effects of Bile Acid Sequestrants
  • Constipation and bloating
  • Interference with fat-soluble vitamin absorption (A, D, E, K)
Contraindications of Bile Acid Sequestrants
  • Bowel obstruction
  • Severe hypertriglyceridemia
Mechanism of Action of Nicotinic Acid (Niacin)
  • Inhibits triglyceride synthesis in the liver
  • Reduces VLDL and LDL levels
  • Increases HDL levels
Indications of Nicotinic Acid
  • Hypertriglyceridemia
  • Combined hyperlipidemia
Adverse Effects of Nicotinic Acid
  • Flushing and itching (prostaglandin-mediated, reduced by aspirin)
  • Hepatotoxicity
  • Hyperuricemia (may exacerbate gout)
Contraindications of Nicotinic Acid
  • Peptic ulcer disease
  • Severe liver disease
  • Gout
Role of Omega Fatty Acids in Lipid Management
  • Reduce triglyceride levels
  • Anti-inflammatory properties
  • Cardioprotective effects
Presentation for Antihyperlipidemic Drugs



                                                                      END OF THE CHAPTER

 You may also like read more: 
SHARE

Owner

Hi. I’m Writer of Researchsop.com. ’ ’ Please share these SOPs to all concern pharma people for their development. I like to fullfill the need of curious people. These things inspire me to make things looks better.

  • Image
  • Image
  • Image
  • Image
  • Image
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment